Why the study?
Does hemodialysis alter plasma concentrations of BNP, ANP, cortisol, and thyroid hormones in patients with chronic renal failure?
Population
30 patients with chronic renal failure undergoing hemodialysis, and 20 control subjects
Comparison
Hemodialysis vs Pre-hemodialysis baseline and healthy controls
Design
Cohort
Follow-up
Duration of a single hemodialysis session
Authors
Loading...
May support BNP/ANP as volume status markers in HD; leaves open prospective validation before guiding therapy.
Does hemodialysis alter plasma concentrations of BNP, ANP, cortisol, and thyroid hormones in patients with chronic renal failure?
BNP and ANP plasma concentrations decrease significantly during hemodialysis, supporting their utility as sensitive indicators of extracellular fluid volume status in patients with chronic renal failure.
Haug et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: